ImmunityBio secures $100 million in financing with debt conversion

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. GMAB
4. ACCV
5. FLG
6. META
7. FICO
8. SMMT
9. QQQ
10. SPCX

Go back to ImmunityBio secures $100 million in financing with debt conversion

ImmunityBio Strengthens Balance Sheet with $100 Million of Financing Transactions Including $75 Million of Non-Dilutive Financing to Support Global Expansion and Advancement of Broader Immunotherapy P

March 31, 2026 7:30 AM EDT

ImmunityBio to receive $75 million in non-dilutive funding under existing Revenue Interest Purchase Agreement (RIPA) with Oberland Capital, bringing total committed capital to $375 million Simultaneously conversion of $25 million of the outstanding promissory note held by Nant Capital, an entity affiliated with Executive Chairman bolstering ImmunityBios balance sheet with reduction in the debt Proceeds strengthen ImmunityBios balance sheet and support global expansion following recent approvals, while advancing companys broader immunotherapy pipeline

CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc.... More